Letter to the Editor
Leukemia advance online publication 10 July 2008; doi: 10.1038/leu.2008.187
High-throughput mutational screen of the tyrosine kinome in chronic myelomonocytic leukemia
J W Tyner1,6, M M Loriaux2,6, H Erickson1, C A Eide1, J Deininger1, M MacPartlin1, S G Willis1, T Lange3, B J Druker1,4, T Kovacsovics1, R Maziarz1, N Gattermann5 and M W Deininger1
- 1Division of Hematology and Medical Oncology, Oregon Health and Science University Cancer Institute, Portland, OR, USA
- 2Department of Pathology, Oregon Health and Science University, Portland, OR, USA
- 3Department of Hematology/Oncology, University of Leipzig, Leipzig, Germany
- 4Howard Hughes Medical Institute, Portland, OR, USA
- 5Klinik für Hämatologie, Onkologie und klinische Immunologie, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany
E-mail: deininge@ohsu.edu
6These authors contributed equally to this work.
Top of page
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Journal of Cerebral Blood Flow & Metabolism Original Article
Modern Pathology Strategic Planning
JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia
Leukemia Letter